Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$856M |
| 2 |
Meta Platforms (Facebook)
META
|
+$647M |
| 3 |
NVIDIA
NVDA
|
+$615M |
| 4 |
Berkshire Hathaway Class A
BRK.A
|
+$304M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$301M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.03B |
| 2 |
UnitedHealth
UNH
|
+$686M |
| 3 |
Tesla
TSLA
|
+$387M |
| 4 |
Abbott
ABT
|
+$380M |
| 5 |
Chevron
CVX
|
+$328M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.26% |
| 2 | Healthcare | 16.96% |
| 3 | Consumer Discretionary | 12.82% |
| 4 | Consumer Staples | 9.14% |
| 5 | Industrials | 9.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EGLX
3751
DELISTED
Enthusiast Gaming Holdings Inc. Common Stock
EGLX
| $23K | ﹤0.01% |
+44,800
| New | +$21.4K |
|
|
SQZ
3752
DELISTED
SQZ Biotechnologies Company
SQZ
| $23K | ﹤0.01% |
83,603
+9,300
| +13% | +$5.28K |
|
|
NVIV
3753
DELISTED
InVivo Therapeutics Holdings Corp
NVIV
| $23K | ﹤0.01% |
17,266
+6,241
| +57% | +$7.94K |
|
3754
Aclarion
ACON
$5.47M
| – | – |
0
| – | – |
|
|
ADIL
3755
Adial Pharmaceuticals
ADIL
$7.31M
| $22K | ﹤0.01% |
171
+10
| +6% | +$1.81K |
|
3756
Cineverse
CNVS
$57.1M
| $22K | ﹤0.01% |
11,363
-217
| -2% | -$1.3K |
|
3757
China Pharma Holdings
CPHI
$47.4M
| $22K | ﹤0.01% |
1,277
-2,130
| -63% | -$37.4K |
|
|
FLNT
3758
Fluent
FLNT
$103M
| $22K | ﹤0.01% |
5,750
+400
| +7% | +$1.68K |
|
3759
IceCure Medical
ICCM
$9.66M
| $22K | ﹤0.01% |
+630
| New | +$22.6K |
|
|
PTN
3760
Palatin Technologies
PTN
$13.5M
| $22K | ﹤0.01% |
211
-16
| -7% | -$1.9K |
|
3761
Twin Vee PowerCats
VEEE
$6.65M
| $22K | ﹤0.01% |
29
-63
| -68% | -$38.8K |
|
3762
Anghami
ANGH
$29.1M
| $21K | ﹤0.01% |
+1,830
| New | +$23.9K |
|
|
EM
3763
DELISTED
Smart Share Global Ltd
EM
| $21K | ﹤0.01% |
+22,000
| New | +$20.9K |
|
3764
FGI Industries
FGI
$8.07M
| $21K | ﹤0.01% |
+2,420
| New | +$21.8K |
|
3765
iSpecimen
ISPC
$2.66M
| $21K | ﹤0.01% |
+19
| New | +$22.2K |
|
3766
Nephros
NEPH
$38M
| $21K | ﹤0.01% |
13,705
-9,495
| -41% | -$14K |
|
3767
Ostin Technology Group
OST
| $21K | ﹤0.01% |
104
-114
| -52% | -$28.9K |
|
3768
Meiwu Technology Co
WNW
$3.19M
| $20K | ﹤0.01% |
2
+1
| +100% | +$13.3K |
|
|
SFE
3769
DELISTED
Safeguard Scientifics, Inc.
SFE
| $20K | ﹤0.01% |
12,000
+1,400
| +13% | +$2.44K |
|
|
LFLY
3770
DELISTED
Leafly Holdings, Inc. Common Stock
LFLY
| $20K | ﹤0.01% |
3,430
+410
| +14% | +$2.78K |
|
3771
New Concept Energy
GBR
$3.39M
| $19K | ﹤0.01% |
15,500
-1,900
| -11% | -$2.06K |
|
|
IMCC
3772
IM Cannabis
IMCC
$1M
| $19K | ﹤0.01% |
+3,383
| New | +$17.6K |
|
|
INCR
3773
Intercure
INCR
$56.9M
| $19K | ﹤0.01% |
11,200
-33,487
| -75% | -$73.3K |
|
3774
Newegg Commerce
NEGG
$276M
| $19K | ﹤0.01% |
+796
| New | +$18K |
|
3775
Precipio
PRPO
$37.2M
| $19K | ﹤0.01% |
2,452
+495
| +25% | +$5.6K |
|
Similar funds
Renaissance Technologies's Q2 2023 Portfolio in Review
As of Q2 2023, Renaissance Technologies held 4,468 positions worth $69.4B, down 7.9% from $75.4B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Renaissance Technologies withdrew a net $8.1B in Q2 2023, closing 599 positions and reducing 1,691 holdings. Its most notable exit was UnitedHealth, an estimated $686M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 17% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Renaissance Technologies opened a new position in Berkshire Hathaway Class A worth $316M.
- Renaissance Technologies's largest Q2 2023 buy was Berkshire Hathaway Class A: 611 shares worth $316M.
- Renaissance Technologies added most to Apple in Q2 2023, an estimated $856M increase.
- Renaissance Technologies's biggest Q2 2023 reduction was Amazon, cutting an estimated $1.03B.
- Renaissance Technologies fully exited UnitedHealth in Q2 2023, selling an estimated $686M.
- Renaissance Technologies's ten largest holdings make up 12% of its $69.4B portfolio in Q2 2023.
- Renaissance Technologies opened 542 new positions and closed 599 in Q2 2023.
- Renaissance Technologies's portfolio value fell 7.9% quarter-over-quarter to $69.4B.
Based on Renaissance Technologies's 13F filing for Q2 2023, filed 11 Aug 2023.